Yanmin Xu

1.9k citations

24 papers · 1.6k indexed · h-index 18

Co-authors: Cheng Qian Zhi Yang Juanjuan Shan Limei Liu Xiu‐Wu Bian Junjie Shen X Y Feng Ping Bie
Topics: Cancer Cells and Metastasis (8 papers)MicroRNA in disease regulation (6 papers)CAR-T cell therapy research (5 papers)
Cited by: Cancer Research Hepatology Oncology
Journals: ACS Nano PLoS ONE Hepatology
Partner nations: China United States Spain

In The Last Decade

Yanmin Xu

22 papers receiving 1.6k citations

Peers

Countries citing papers authored by Yanmin Xu

Since Specialization

Citations

This map shows the geographic impact of Yanmin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmin Xu more than expected).

Fields of papers citing papers by Yanmin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanmin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmin Xu. The network helps show where Yanmin Xu may publish in the future.

Co-authorship network of co-authors of Yanmin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanmin Xu. A scholar is included among the top collaborators of Yanmin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanmin Xu. Yanmin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bidirectional Mendelian randomization analysis of inflammatory factors and sleep related traits 2025 ·Brain Behavior & Immunity - Health ·Zhongxing Liao,Sheng Guo,(unknown),Yanmin Xu,Rui Zheng,(unknown),Guoan Zhao,(unknown),Xiaohong Kang,(unknown)	0
2	Mechanical Properties Measured by Atomic Force Microscopy Help Evaluate Different Constructions of Re-engineered Chimeric Antigen Receptor-T Models 2025 ·ACS Nano ·(unknown),Xuejiao Chen,Junjie Shen,(unknown),Jun Chen,Weisheng Zhao,Yong Qi,Xia Huang,(unknown),Yanmin Xu,Juan Hong,Qian Cheng,Zhiyi Ye	0
3	Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma 2023 ·Frontiers in Immunology ·Chengcheng Zhang,Linling Wang,Qianzhen Zhang,Junjie Shen,Xia Huang,Meiling Wang,Yi-Hsun Huang,Jun Chen,Yanmin Xu,Wenxu Zhao,Yanan Qi,Yunyan Li,(unknown),Zhi Yang,Cheng Qian	21
4	RUNX3 improves CAR-T cell phenotype and reduces cytokine release while maintaining CAR-T function 2023 ·Medical Oncology ·Xiuxiu Zhu,(unknown),Jiadong Gao,Junjie Shen,Yanmin Xu,Chengcheng Zhang,Cheng Qian	12
5	Simultaneous editing of TCR, HLA-I/II and HLA-E resulted in enhanced universal CAR-T resistance to allo-rejection 2022 ·Frontiers in Immunology ·(unknown),Xiuxiu Zhu,Yanmin Xu,Jun Chen,Hongtao Zhang,Zhi Yang,Yanan Qi,Juan Hong,Yunyan Li,Guixue Wang,Junjie Shen,Cheng Qian	31
6	KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program 2019 ·Cancer Letters ·Yanmin Xu,Huailong Xu,Mingyuan Li,Hua Wu,(unknown),Jun Chen,Juanjuan Shan,Xuejiao Chen,Junjie Shen,Qinghua Ma,Jingxia Liu,Meiling Wang,Wenxu Zhao,Juan Hong,Yanan Qi,Chao Yao,Qianzhen Zhang,Zhi Yang,Cheng Qian,Jianming Li	53
7	FBLN3 inhibits the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway 2019 ·Neoplasma ·Haiyan Mao,(unknown),(unknown),Yongfen Xu,Yanmin Xu,(unknown),(unknown),(unknown),(unknown),Ping Bo	9
8	MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting Tcf3 2017 ·Oncotarget ·Qianzhen Zhang,Zhi Yang,Juanjuan Shan,Limei Liu,Chungang Liu,Junjie Shen,Xuejiao Chen,Yanmin Xu,Jun Chen,Qinghua Ma,Li Yang,Cheng Qian	9
9	MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer 2016 ·Cancer Research ·Li Su,Yongli Luo,Zhi Yang,H. J. Yang,Chao Yao,Feifei Cheng,Juanjuan Shan,Jun Chen,Fangfang Li,Limei Liu,Chungang Liu,Yanmin Xu,Lupin Jiang,Deyu Guo,Jesús Prìeto,Matías A. Ávila,Junjie Shen,Cheng Qian	57
10	Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma 2016 ·Cancer Letters ·Yongli Luo,Zhi Yang,Li Su,Juanjuan Shan,Huailong Xu,Yanmin Xu,Limei Liu,Wei Zhu,Xuejiao Chen,Chungang Liu,Jun Chen,Chao Yao,Feifei Cheng,Chengcheng Zhang,Qinghua Ma,Junjie Shen,Cheng Qian	38
11	IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer 2016 ·Stem Cells ·Chao Yao,Li Su,Juanjuan Shan,(unknown),Limei Liu,Chungang Liu,Yanmin Xu,Zhi Yang,Xiu‐Wu Bian,Jimin Shao,Jianming Li,Maode Lai,Junjie Shen,Cheng Qian	105
12	MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways 2015 ·Cancer Letters ·Yanmin Xu,(unknown),Leina Ma,Juanjuan Shan,Junjie Shen,Zhi Yang,Limei Liu,Yongli Luo,Chao Yao,Cheng Qian	135
13	Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes 2014 ·Cancer Research ·Leina Ma,Jia Liu,Limei Liu,Guangjie Duan,Qingliang Wang,Yanmin Xu,X Y Feng,Juanjuan Shan,Junjie Shen,Zhi Yang,Ping Bie,You‐Hong Cui,Xiu‐Wu Bian,Jesús Prìeto,Matías A. Ávila,Cheng Qian	74
14	Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification 2013 ·Cancer Letters ·Chungang Liu,Limei Liu,Juanjuan Shan,Junjie Shen,Yanmin Xu,Qianzhen Zhang,Zhi Yang,Lin Wu,X Y Feng,Ping Bie,You‐Hong Cui,Xia Zhang,Xiu‐Wu Bian,Cheng Qian	66
15	Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1 2013 ·PLoS ONE ·Chungang Liu,Limei Liu,Xuejiao Chen,Junjie Shen,Juanjuan Shan,Yanmin Xu,Zhi Yang,Lin Wu,X Y Feng,Ping Bie,You‐Hong Cui,Xiu‐Wu Bian,Cheng Qian	141
16	Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model 2012 ·PLoS ONE ·Zhi Yang,Qianzhen Zhang,(unknown),Juanjuan Shan,Junjie Shen,Limei Liu,Yanmin Xu,X Y Feng,Ping Bie,Xia Zhang,You‐Hong Cui,Xiu‐Wu Bian,Cheng Qian	45
17	Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma 2012 ·Hepatology ·Juanjuan Shan,Junjie Shen,Limei Liu,X Y Feng,Chuan Xu,Guangjie Duan,Yanmin Xu,Qinghua Ma,Zhi Yang,Qianzhen Zhang,Leina Ma,Jia Liu,Senlin Xu,Xiaochu Yan,Ping Bie,You‐Hong Cui,Xiu‐Wu Bian,Cheng Qian	261
18	Does Hepatic Ischemia–Reperfusion Injury Induced by Hepatic Pedicle Clamping Affect Survival after Partial Hepatectomy for Hepatocellular Carcinoma? 2012 ·World Journal of Surgery ·X Y Feng,Wan‐Yee Lau,Yanmin Xu,Lin Wu,Cheng Qian,Ping Bie	19
19	MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest 2011 ·Cancer Letters ·Yanmin Xu,X Y Feng,Leina Ma,Juanjuan Shan,Junjie Shen,Zhi Yang,Jia Liu,You‐Hong Cui,Xiu‐Wu Bian,Ping Bie,Cheng Qian	177
20	Reduction‐Sensitive Reversibly Crosslinked Biodegradable Micelles for Triggered Release of Doxorubicin 2009 ·Macromolecular Bioscience ·Yanmin Xu,Fenghua Meng,Ru Cheng,Zhiyuan Zhong	89

About Yanmin Xu

Yanmin Xu is a scholar working on Cancer Research, Oncology and Geriatrics and Gerontology, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), MicroRNA in disease regulation (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Cancer Research (566 citations), Hepatology (159 citations) and Oncology (507 citations). Yanmin Xu has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Cheng Qian, Zhi Yang, Juanjuan Shan, Limei Liu, Xiu‐Wu Bian, Junjie Shen, X Y Feng, Ping Bie, You‐Hong Cui and Leina Ma. Their work appears in journals such as ACS Nano, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact